Morbidity and mortality in children with anemia at initiation of dialysis

Pediatric Nephrology

Volumn 18, Issue 10, 2003, Pages 1055-1062

  Warady, Bradley A ^a   Ho, Martin ^b  

^a CHILDREN S MERCY HOSPITAL   (United States)

^b EMMES CORPORATION   (United States)

Author keywords

Chronic renal failure; Erythropoietin; Hematocrit; Hemoglobin; Iron

Indexed keywords

IRON DERIVATIVE; RECOMBINANT ERYTHROPOIETIN;

ANEMIA; ARTICLE; CAUSE OF DEATH; CHILD; CHRONIC INFLAMMATION; CONTROLLED STUDY; DATA BASE; DISEASE MARKER; FEMALE; FOCAL GLOMERULOSCLEROSIS; GLOMERULONEPHRITIS; HEART DISEASE; HEMATOCRIT; HEMODIALYSIS; HUMAN; INFANT; KIDNEY DISEASE; LENGTH OF STAY; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; MULTIVARIATE ANALYSIS; NONBIOLOGICAL MODEL; PERITONEAL DIALYSIS; PRIORITY JOURNAL; RECURRENT INFECTION; RISK ASSESSMENT; SURVIVAL TIME; UNITED STATES;

ADOLESCENT; AGE DISTRIBUTION; ANEMIA; CHILD; CHILD, PRESCHOOL; FEMALE; HEMATOCRIT; HEMOGLOBINS; HUMANS; INFANT; INFANT, NEWBORN; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MORBIDITY; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RENAL DIALYSIS; RISK FACTORS; SEX DISTRIBUTION;

EID: 0141954949     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-003-1214-1     Document Type: Article

References (46)

1. (2002) The anemia of chronic renal insufficiency (CRI). United Resource Networks, Minneapolis, Minn.
2. Kazmi WH, Kausz AT, Khan S, Abichandani R, Ruthazer R, Obrador GT, Pereira BJ (2001) Anemia: an early complication of chronic renal insufficiency. Am J Kidney Dis 38:803-812
3. Obrador GT, Arora P, Kausz AT, Pereira BJ (1998) Pre-end-stage renal disease care in the United States: a state of disrepair. J Am Soc Nephrol 9:S44-S54
4. Obrador GT, Roberts T, St. Peter WL, Frazier E, Pereira BJG, Collins AJ (2001) Trends in anemia at initiation of dialysis in the United States. Kidney Int 60:1875-1884
5. Obrador GT, Ruthazer R, Arora P, Kausz AT, Pereira BJ (1999) Prevalence of and factors associated with suboptimal care before initiation of dialysis in the United States. J Am Soc Nephrol 10:1793-1800
6. Collins AJ, Ma JZ, Ebben J (2000) Impact of hematocrit on morbidity and mortality. Semin Dial 20:345-349
7. Eknoyan G (2001) The importance of early treatment of the anaemia of chronic kidney disease. Nephrol Dial Transplant 16:45-49
8. Gerson A, Fivush BA, Kaskel F, Weiss L, Powe NR, Furth SL (2001) Functional outcome in adolescents with renal failure: assessing a generic health status questionnaire. Perit Dial Int 21:S89
9. Kausz AT, Obrador GT, Pereira BJG (2000) Anemia management in patients with chronic renal insufficiency. Am J Kidney Dis 36:S39-S51
10. Macdougall IC (2000) How to improve survival in pre-dialysis patients. Nephron 85:15-22
11. Moreno F, Aracil F, Pérez R, Valderrábano F (1996) Controlled study on the improvement of quality of life in elderly hemodialysis patients after correcting end-stage renal disease - related anemia with erythropoietin. Am J Kidney Dis 27:548-556
12. Painter P, Moore G, Carlson L, Paul S, Myll J, Phillips W, Haskell W (2002) Effects of exercise training plus normalization of hematocrit on exercise capacity and health-related quality of life. Am J Kidney Dis 39:257-265
13. Pattaragarn A, Warady BA, Sabath RJ, Reece M (2002) Exercise capacity in children with end-stage renal disease. Perit Dial Int 22:S74
14. Pereira BJ (2000) Optimization of pre-ESRD care: the key to improved dialysis outcomes. Kidney Int 57:351-365
15. Revicki D, Brown R, Feeny D, Henry D, Teehan B, Rudnick M, Benz R (1995) Health-related quality of life associated with recombinant human erythropoietin therapy for predialysis chronic renal disease patients. Am J Kidney Dis 25:548-554
16. Warady BA, Jabs K (1995) New hormones in the therapeutic arsenal of chronic renal failure: growth hormone and erythropoietin. Pediatr Clin North Am 42:1551-1577
17. Warady BA, Sabath RJ, Smith CA, Alon U, Hellerstein S (1991) Recombinant human erythropoietin therapy in pediatric patients receiving long-term peritoneal dialysis. Pediatr Nephrol 5:718-723
18. Ma JZ, Ebben J, Xia H, Collins AJ (1999) Hematocrit level and associated mortality in hemodialysis patients. J Am Soc Nephrol 10:610-619
19. Xia H, Ebben J, Ma JZ, Collins AJ (1999) Hematocrit levels and hospitalization risks in hemodialysis patients. J Am Soc Nephrol 10:1309-1316
20. (1997) NKF DOQI clinical practice guidelines for the treatment of chronic kidney failure. Am J Kidney Dis 30 [Suppl 3]:S192-S240
21. Jabs K, Warady BA (1999) The impact of the Dialysis Outcomes Quality Initiative Guidelines on the care of the pediatric end-stage renal disease patient. Adv Ren Replace Ther 6:97-106
22. NKF-K/DOQI (2001) Clinical practice guidelines for the treatment of anemia of chronic kidney disease. National Kidney Foundation, New York, pp 33-49
23. (2001) United States Renal Data System's 2000 Annual Data Report. Am J Kidney Dis 38:S107-S116
24. Neu AM, Ho PL, McDonald RA, Warady BA (2002) Chronic dialysis in children and adolescents. The 2001 NAPRTCS annual report. Pediatr Nephrol 17:656-663
25. Eschbach JW, Egrie JC, Downing MR, Browne JK, Adamson JW (1987) Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. N Engl J Med 316:73-78
26. Hayashi T, Suzuki A, Shoji T, Togawa M, Okada N, Tsubakihara Y, Imai E, Hori M (2000) Cardiovascular effect of normalizing the hematocrit level during erythropoietin therapy in predialysis patients with chronic renal failure. Am J Kidney Dis 35:250-256
27. Marsh JT, Brown WS, Wolcott D, Carr CR, Harper R, Schweitzer SV, Nissenson AR (1991) rHuEPO treatment improves brain and cognitive function of anemic dialysis patients. Kidney Int 39:155-163
28. Metry G, Wikström B, Valind S, Sandhagen B, Linde T, Beshara S, Långström B, Danielson B (1999) Effect of normalization of hematocrit on brain circulation and metabolism in hemodialysis patients. J Am Soc Nephrol 10:854-863
29. Pascual J, Teruel JL, Molla JL, Liano F, Jimenez-Mena M, Ortuno J (1991) Regression of left ventricular hypertrophy after partial correction of anemia with erythropoietin in patients on hemodialysis: a prospective study. Clin Nephrol 35:280-287
30. Stivelman JC (2000) Benefits of anaemia treatment on cognitive function. Nephrol Dial Transplant 15:29-35
31. Eschbach JW, Abdulhadi MBJ, Delano B, Downing M, Egrie J, Lundin A, Nissenson A, Ogden D, Paganini E, Rader B, Rutsky E, Stivelman J, Stone W, Teschan P, Van Stone J, Van Wyck D, Zuckerman K, Adamson J (1989) Recombinant human erythropoietin in anemic patients with end-stage renal disease. Results of a phase III multicenter clinical trial. Ann Intern Med 111:992-1000
32. Lerner GR, Warady BA, Sullivan EK, Alexander SR (1999) Chronic dialysis in children and adolescents. The 1996 annual report of the North American Pediatric Renal Transplant Cooperative Study. Pediatr Nephrol 13:404-417
33. Pereira BJG (2001) The renal anemia management period (RAMP): a proactive approach to managing the anemia of chronic kidney disease. Contemp Dial Nephrol :41-47
34. Collins AJ (2002) Influence of target hemoglobin in dialysis patients on morbidity and mortality. Kidney Int 61:S44-S48
35. Foley RN, Parfrey PS, Sarnak MJ (1998) Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 32:S112-S119
36. Ismail N, Becker BN (1998) An opportunity to intervene: erythropoietin for the treatment of anaemia in pre-dialysis patients. Nephrol Dial Transplant 13:14-17
37. Levin A (1999) How should anaemia be managed in pre-dialysis patients? Nephrol Dial Transplant 14:66-74
38. Levin A (2002) Anemia and left ventricular hypertrophy in chronic kidney disease populations: a review of the current state of knowledge. Kidney Int 61:535-538
39. Murphy ST, Parfrey PS (2000) The impact of anemia correction on cardiovascular disease in end-stage renal disease. Semin Nephrol 20:350-355
40. Mitsnefes MM, Daniels SR, Schwartz SM, Khoury P, Strife CF (2001) Changes in left ventricular mass in children and adolescents during chronic dialysis. Pediatr Nephrol 16:318-323
41. Chavers BM, Li S, Collins AJ, Herzog CA (2002) Cardiovascular disease in pediatric chronic dialysis patients. Kidney Int 62:648-653
42. Parekh RS, Carroll CE, Wolfe RA, Port FK (2002) Cardiovascular mortality in children and young adults with end-stage kidney disease. J Pediatr 141:191-197
43. Muirhead N, Hodsman AB (1990) Occult infection and resistance of anaemia to rHuEpo therapy in renal failure. Nephrol Dial Transplant 5:232-234
44. Bellizzi V (2002) Influence of the cyclic variation of hydration status on hemoglobin levels in hemodialysis patients. Am J Kidney Dis 40:549-555
45. Frankenfield M, Neu AM, Warady BA, Watkins SL, Friedman AL, Fivush BA (2002) Adolescent hemodialysis: results of the 2000 ESRD Clinical Performance Measures Project. Pediatr Nephrol 17:10-15
46. Stevens L, Stigant C, Levin A (2002) Should hemoglobin be normalized in patients with chronic kidney disease? Semin Dial 15:8-13